Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000034

Chief Commercial Officer acquired 512,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Phillips Matthew V · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-08-23 Grant or award : show line 1 in the form +512,500 $1.07 $548,375 512,500 I
Loading xslF345X03/primary_doc.xml…